Found 0 matching trials
A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer
PHASE1This study is testing narmafotinib, a type of drug called a focal adhesion ...
Status
Active Not Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
PHASE2The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Location
Shanghai Cancer Center
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
PHASE3The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Location
The second affiliated hospital of Zhejiang University
A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1This study will consider the safety and effectiveness of a study drug, CAN0...
Location
EDOG - Institut Bergonie - PPDS
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
PHASE2The purpose of this study is to estimate safety of GVAX Pancreas Vaccine (G...
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE3The purpose of this study is to evaluate the safety and efficacy of a novel...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
PHASE2The purpose of this study is evaluate the efficacy and safety of FOLFIRINOX...
Location
H. Lee Moffitt Cancer Center and Research Institute
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
PHASE3A prospective, multicenter, open label, randomized phase III study to evalu...
Location
Banner MD Anderson Cancer Center
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
PHASE1This partially randomized phase I/II trial studies the side effects and bes...
Location
Anchorage Associates in Radiation Medicine
PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)
PHASE1Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor s...
Location
University of Vermont Medical Center